News

Abstract: Detection of pulmonary nodules with ground glass opacity (GGO) is a difficult task in radiology. Follow up is often required in medical fields. But diagnosis based on CT images are dependent ...
30+ studies across diverse conditions illuminate the unique value of functional lung imaging with Xenon MRI DURHAM, NC and LONDON, May 15, 2025 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) ...
Massachusetts-based high-purity rare gas technologies company EFC Gases & Advanced Materials has secured a five-year contract to support NASA’s xenon gas reprocessing needs. Worth up to $5m over its ...
The idea was to summit the Everest by altering the acclimatization process that could allow them to reach the peak in under seven days by by inhaling a noble gas called xenon ahead of the expedition.
Xenon Pharmaceuticals XENE reported a loss of 83 cents per share for the first quarter of 2025, narrower than the Zacks Consensus Estimate of a loss of 94 cents. The company had incurred a loss of ...
While this timing represents a modest shift from our prior guidance, we are encouraged that we are nearing the end of this important study which represents a significant milestone for Xenon ...
Xenon Pharmaceuticals (XENE) closed the last trading session at $38.28, gaining 30.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets ...
An apologetic former student has finally returned three books they borrowed from a university library 20 years ago. The overdue books, along with a handwritten note, were delivered to the ...
The overdue books were delivered to Lady Margaret Hall with a note apologising for their late return An apologetic former student has finally returned three books they borrowed from a university ...
Church bells will ring out and beacons will be lit across Berkshire as it commemorates 80 years since VE Day. Thursday 8 May marks the anniversary of the day fighting against Nazi Germany in ...
Xenon Pharmaceuticals Inc. VANCOUVER, British Columbia and BOSTON, May 02, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company ...